Published in Kidney Int on March 16, 2011
Mouse model of ischemic acute kidney injury: technical notes and tricks. Am J Physiol Renal Physiol (2012) 1.36
miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation (2013) 0.96
RGS4 inhibits angiotensin II signaling and macrophage localization during renal reperfusion injury independent of vasospasm. Kidney Int (2014) 0.78
Suppression of renal TRPM7 may alleviate kidney injury in the renal transplantation. World J Urol (2013) 0.78
Accessory proteins for heterotrimeric G-proteins in the kidney. Front Physiol (2015) 0.77
CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model. Transplantation (2014) 0.77
Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks. Kidney Int (2016) 0.77
Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury. Kidney Int (2013) 0.76
Modification and functional inhibition of regulator of G-protein signaling 4 (RGS4) by 4-hydroxy-2-nonenal. Chem Res Toxicol (2013) 0.76
A GAP in our knowledge of vascular signaling in acute kidney injury. Kidney Int (2011) 0.75
Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol (2005) 18.76
Acute renal failure. N Engl J Med (1996) 8.83
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol (2006) 6.86
Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54
GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell (1996) 4.76
Structure of RGS4 bound to AlF4--activated G(i alpha1): stabilization of the transition state for GTP hydrolysis. Cell (1997) 4.74
RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature (1996) 3.20
Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int (2002) 3.07
An essential role of N-terminal arginylation in cardiovascular development. Science (2002) 3.06
Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature (1996) 2.83
RGS proteins and signaling by heterotrimeric G proteins. J Biol Chem (1997) 2.82
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest (2003) 2.68
The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature (2005) 2.55
Mammalian RGS proteins: barbarians at the gate. J Biol Chem (1998) 2.34
The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med (1999) 2.18
RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha. Proc Natl Acad Sci U S A (1997) 2.14
Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest (2009) 1.79
RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice. J Mol Cell Cardiol (2001) 1.72
Comparison of outcome from intensive care admission after adjustment for case mix by the APACHE III prognostic system. Chest (1999) 1.71
Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest (1997) 1.48
Permanent detrimental effect of nonimmunological factors on long-term renal graft survival: a parsimonious model of time-dependency. Transplantation (2000) 1.42
Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther (2006) 1.42
Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells. Proc Natl Acad Sci U S A (1997) 1.38
Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol (2000) 1.36
N-terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol Pharmacol (2007) 1.35
Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling. Mol Biol Cell (2004) 1.29
Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. Mol Pharm (2009) 1.28
A simple, sensitive, and specific radioreceptor assay for inositol 1,4,5-trisphosphate in biological tissues. Biochem Biophys Res Commun (1989) 1.26
Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol (1999) 1.14
Vasoactive factors in sickle cell disease: in vitro evidence for endothelin-1-mediated vasoconstriction. Am J Hematol (2004) 1.11
RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clin Sci (Lond) (2009) 1.06
Interleukin-1beta up-regulates RGS4 through the canonical IKK2/IkappaBalpha/NF-kappaB pathway in rabbit colonic smooth muscle. Biochem J (2008) 1.04
Pathophysiological role of endothelin in acute renal failure. Life Sci (1990) 1.03
Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int (1999) 1.00
Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway. Am J Physiol Cell Physiol (2009) 1.00
Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion. J Endocrinol (2007) 0.98
Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am J Physiol Renal Physiol (2007) 0.93
Support of renal blood flow after ischaemic-reperfusion injury by endogenous formation of nitric oxide and of cyclo-oxygenase vasodilator metabolites. Br J Pharmacol (1993) 0.91
Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex. Neuroscience (2006) 0.89
Multivalency-assisted control of intracellular signaling pathways: application for ubiquitin- dependent N-end rule pathway. Chem Biol (2009) 0.89
Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice. J Hypertens (2005) 0.89
RGS4 controls renal blood flow and inhibits cyclosporine-mediated nephrotoxicity. Am J Transplant (2009) 0.88
The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function. Transplantation (2001) 0.87
Endothelins: vasoactive modulators of renal function in health and disease. Pharmacol Ther (2001) 0.85
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat. Hypertension (1996) 0.81
Real-time monitoring of nitric oxide in ischemia-reperfusion rat kidney. Urol Res (2000) 0.80
Pressure diuresis and natriuresis in DOCA-salt mice. Kidney Int (1997) 0.79
Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs. J Pharmacol Exp Ther (1993) 0.77
Akt1 is required for physiological cardiac growth. Circulation (2006) 4.25
ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab (2006) 3.38
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest (2003) 2.68
A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell (2010) 2.37
Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell (2004) 2.31
Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol (2005) 2.27
The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol (2008) 1.99
Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure. Kidney Int (2009) 1.95
Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81
The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J Clin Invest (2003) 1.61
Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload. Circulation (2004) 1.59
Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol (2005) 1.54
Impaired micro-RNA pathways diminish osteoclast differentiation and function. J Biol Chem (2008) 1.53
Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.52
Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem (2006) 1.50
A microRNA expression signature of osteoclastogenesis. Blood (2011) 1.49
BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol (2003) 1.45
Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest (2013) 1.42
Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. J Mol Cell Cardiol (2005) 1.42
Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus. Am J Nephrol (2015) 1.42
ZnT-1 protects HL-1 cells from simulated ischemia-reperfusion through activation of Ras-ERK signaling. J Mol Med (Berl) (2011) 1.40
Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem (2004) 1.40
CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas. J Am Soc Nephrol (2009) 1.40
Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol (2006) 1.37
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol (2008) 1.35
The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation. Diabetes (2009) 1.32
Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy. Kidney Int (2003) 1.29
Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. Mol Pharm (2009) 1.28
Myocardial dysfunction after electrical defibrillation. Resuscitation (2002) 1.25
Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus. Am J Physiol Heart Circ Physiol (2009) 1.24
Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus. Circ Cardiovasc Genet (2012) 1.22
14-3-3 protein regulates Ask1 signaling and protects against diabetic cardiomyopathy. Biochem Pharmacol (2008) 1.17
Zinc ions and cation diffusion facilitator proteins regulate Ras-mediated signaling. Dev Cell (2002) 1.17
Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol (2004) 1.10
Cellular recognition of trimyristoylated peptide or enterobacterial lipopolysaccharide via both TLR2 and TLR4. J Biol Chem (2007) 1.09
The 14-3-3tau phosphoserine-binding protein is required for cardiomyocyte survival. Mol Cell Biol (2006) 1.08
Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem (2003) 1.07
PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility. J Biol Chem (2002) 1.06
Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res (2011) 1.06
Serine 58 of 14-3-3zeta is a molecular switch regulating ASK1 and oxidant stress-induced cell death. Mol Cell Biol (2009) 1.06
TRB3 function in cardiac endoplasmic reticulum stress. Circ Res (2010) 1.04
Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease. Am J Nephrol (2013) 1.03
Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells. J Bone Miner Res (2004) 1.01
Differential role of 14-3-3 family members in Xenopus development. Dev Dyn (2006) 1.00
Rho-dependent Rho kinase activation increases CD44 surface expression and bone resorption in osteoclasts. J Biol Chem (2003) 0.99
The BMP-7-Smad1/5/8 pathway promotes kidney repair after obstruction induced renal injury. J Urol (2011) 0.99
Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J Bone Miner Res (2009) 0.96
Monophyly or paraphyly--the taxonomy of Holcoglossum (Aeridinae: Orchidaceae). PLoS One (2012) 0.95
G-protein signaling participates in the development of diabetic cardiomyopathy. Diabetes (2004) 0.95
Cation diffusion facilitator proteins modulate Raf-1 activity. J Biol Chem (2004) 0.95
Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation. J Mol Cell Cardiol (2006) 0.95
Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38α mitogen-activated protein kinase mice. Free Radic Biol Med (2010) 0.94
Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest (2003) 0.94
The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol (2003) 0.94
The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int (2003) 0.93
Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol Dial Transplant (2007) 0.93
Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int (2002) 0.93
Inactivation of 14-3-3 protein exacerbates cardiac hypertrophy and fibrosis through enhanced expression of protein kinase C beta 2 in experimental diabetes. Biol Pharm Bull (2005) 0.92
Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival. Circ Res (2003) 0.92
Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast. J Bone Miner Res (2003) 0.92
Bone morphogenetic protein 7: a novel treatment for chronic renal and bone disease. Curr Opin Nephrol Hypertens (2004) 0.91
Molecular basis for zinc transporter 1 action as an endogenous inhibitor of L-type calcium channels. J Biol Chem (2009) 0.90
Purification of recombinant human cPLA2 gamma and identification of C-terminal farnesylation, proteolytic processing, and carboxymethylation by MALDI-TOF-TOF analysis. Biochemistry (2003) 0.89
Insulin signaling pathways and cardiac growth. J Mol Cell Cardiol (2008) 0.89
Lack of the alanine-serine-cysteine transporter 1 causes tremors, seizures, and early postnatal death in mice. Brain Res (2005) 0.89
Vascular smooth muscle cells in the pathogenesis of vascular calcification. Circ Res (2009) 0.88
Relationships between serum adiponectin and bone density, adiposity and calcified atherosclerotic plaque in the African American-Diabetes Heart Study. J Clin Endocrinol Metab (2013) 0.88
Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol. FEBS Lett (2006) 0.86
Septic shock induced from an implantable cardioverter-defibrillator lead-associated Candida albicans vegetation. J Interv Card Electrophysiol (2005) 0.86
Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption. BMC Cell Biol (2004) 0.86
Bone morphogenetic protein-7: an anti-fibrotic morphogenetic protein with therapeutic importance in renal disease. Curr Opin Nephrol Hypertens (2002) 0.85
Requirement for p38 mitogen-activated protein kinase activity in neointima formation after vascular injury. Circulation (2008) 0.85
The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls. PLoS One (2013) 0.85
Proprotein convertases regulate activity of prostate epithelial cell differentiation markers and are modulated in human prostate cancer cells. J Cell Biochem (2003) 0.84
Grb2 is required for the development of neointima in response to vascular injury. Arterioscler Thromb Vasc Biol (2003) 0.84
Attenuation of CHOP-mediated myocardial apoptosis in pressure-overloaded dominant negative p38α mitogen-activated protein kinase mice. Cell Physiol Biochem (2011) 0.84
Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study. BMC Nephrol (2012) 0.84
Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity. J Mol Cell Cardiol (2010) 0.84
Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosis. J Cell Biochem (2013) 0.84
Interleukin-10-819C>T polymorphism contributed to cancer risk: evidence from 29 studies. Cytokine (2012) 0.83
An unbiased chemical biology screen identifies agents that modulate uptake of oxidized LDL by macrophages. Circ Res (2009) 0.83
The application of phenotypic high-throughput screening techniques to cardiovascular research. Trends Cardiovasc Med (2009) 0.82
Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease. Pediatr Nephrol (2014) 0.82
Role of 14-3-3 proteins in early Xenopus development. Mech Dev (2002) 0.82
Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study. J Clin Endocrinol Metab (2013) 0.82
Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity. J Cell Biochem (2014) 0.81
14-3-3 protein protects against cardiac endoplasmic reticulum stress (ERS) and ERS-initiated apoptosis in experimental diabetes. J Pharmacol Sci (2010) 0.81
In vivo transplantation of neonatal ovine neocartilage allografts: determining the effectiveness of tissue transglutaminase. J Knee Surg (2005) 0.81
Endogenous BMP-7 is a critical molecular determinant of the reversibility of obstruction-induced renal injuries. Am J Physiol Renal Physiol (2011) 0.81
Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am J Nephrol (2014) 0.81
Partial inactivation of cardiac 14-3-3 protein in vivo elicits endoplasmic reticulum stress (ERS) and activates ERS-initiated apoptosis in ERS-induced mice. Cell Physiol Biochem (2010) 0.80
Getting the iron out: preventing and treating heart failure in transfusion-dependent thalassemia. Cleve Clin J Med (2007) 0.79
Swimming stress in DN 14-3-3 mice triggers maladaptive cardiac remodeling: role of p38 MAPK. Am J Physiol Heart Circ Physiol (2006) 0.79
Grb2 is required for atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol (2007) 0.79
Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK. Biochem Biophys Res Commun (2004) 0.79
RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation. Am J Physiol Lung Cell Mol Physiol (2013) 0.78